vTv Therapeutics (VTVT) Competitors $16.21 -0.56 (-3.32%) Closing price 03:59 PM EasternExtended Trading$16.49 +0.28 (+1.70%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VTVT vs. CRGX, NLTX, ACIU, LRMR, CGC, FDMT, YMAB, OGI, ENGN, and RAPTShould you be buying vTv Therapeutics stock or one of its competitors? The main competitors of vTv Therapeutics include CARGO Therapeutics (CRGX), Neoleukin Therapeutics (NLTX), AC Immune (ACIU), Larimar Therapeutics (LRMR), Canopy Growth (CGC), 4D Molecular Therapeutics (FDMT), Y-mAbs Therapeutics (YMAB), Organigram Global (OGI), enGene (ENGN), and Rapt Therapeutics (RAPT). These companies are all part of the "pharmaceutical products" industry. vTv Therapeutics vs. Its Competitors CARGO Therapeutics Neoleukin Therapeutics AC Immune Larimar Therapeutics Canopy Growth 4D Molecular Therapeutics Y-mAbs Therapeutics Organigram Global enGene Rapt Therapeutics CARGO Therapeutics (NASDAQ:CRGX) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership. Which has more volatility and risk, CRGX or VTVT? CARGO Therapeutics has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Does the media favor CRGX or VTVT? In the previous week, CARGO Therapeutics had 1 more articles in the media than vTv Therapeutics. MarketBeat recorded 2 mentions for CARGO Therapeutics and 1 mentions for vTv Therapeutics. vTv Therapeutics' average media sentiment score of 1.16 beat CARGO Therapeutics' score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment CARGO Therapeutics Neutral vTv Therapeutics Positive Do analysts recommend CRGX or VTVT? CARGO Therapeutics presently has a consensus price target of $15.40, indicating a potential upside of 240.71%. vTv Therapeutics has a consensus price target of $35.50, indicating a potential upside of 118.96%. Given CARGO Therapeutics' higher possible upside, equities analysts clearly believe CARGO Therapeutics is more favorable than vTv Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86vTv Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, CRGX or VTVT? vTv Therapeutics has higher revenue and earnings than CARGO Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.98vTv Therapeutics$1.02M50.71-$18.46M-$3.01-5.39 Is CRGX or VTVT more profitable? CARGO Therapeutics' return on equity of -45.93% beat vTv Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -45.93% -39.58% vTv Therapeutics N/A -121.46%-46.75% Do insiders and institutionals have more ownership in CRGX or VTVT? 93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are held by institutional investors. 2.9% of CARGO Therapeutics shares are held by company insiders. Comparatively, 4.2% of vTv Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryvTv Therapeutics beats CARGO Therapeutics on 8 of the 14 factors compared between the two stocks. Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VTVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTVT vs. The Competition Export to ExcelMetricvTv TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.72M$3.06B$5.67B$9.49BDividend YieldN/A2.44%4.05%4.00%P/E Ratio-5.3920.8627.9419.95Price / Sales50.71246.06396.5882.68Price / CashN/A41.9636.1958.45Price / Book3.628.308.635.82Net Income-$18.46M-$55.19M$3.24B$258.42M7 Day Performance0.33%5.07%3.22%1.94%1 Month Performance2.61%17.61%10.72%12.02%1 Year Performance-31.59%7.03%34.94%20.80% vTv Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTVTvTv Therapeutics1.5928 of 5 stars$16.21-3.3%$35.50+119.0%-31.7%$51.72M$1.02M-5.399Positive NewsCRGXCARGO Therapeutics1.6492 of 5 stars$4.52-1.1%$15.40+240.7%-74.4%$210.72MN/A-0.98116High Trading VolumeNLTXNeoleukin TherapeuticsN/A$22.34-1.2%N/A-48.1%$209.95MN/A-7.1890News CoverageGap UpHigh Trading VolumeACIUAC Immune1.4385 of 5 stars$2.08+0.5%$12.00+476.9%-36.6%$207.85M$31.02M-3.59140Positive NewsLRMRLarimar Therapeutics1.7589 of 5 stars$3.26+1.6%$18.50+467.5%-60.1%$205.53MN/A-2.1930CGCCanopy Growth0.4482 of 5 stars$1.12+2.8%N/A-85.7%$200.41M$225.65M-0.283,150FDMT4D Molecular Therapeutics2.2945 of 5 stars$4.24+0.5%$29.56+597.1%-73.7%$195.49M$40K-1.33120News CoverageYMABY-mAbs Therapeutics3.1287 of 5 stars$4.33+0.5%$15.60+260.3%-62.5%$195.17M$87.68M-6.77150News CoveragePositive NewsOGIOrganigram Global0.663 of 5 stars$1.46+0.7%N/A-11.7%$194.21M$117.47M14.60860ENGNenGene2.9232 of 5 stars$3.85+1.6%$23.29+504.8%-56.1%$193.69MN/A-2.3331RAPTRapt Therapeutics4.3365 of 5 stars$11.70+0.2%$19.80+69.2%-42.9%$193.14M$1.53M-0.6180News CoverageAnalyst Upgrade Related Companies and Tools Related Companies CRGX Alternatives NLTX Alternatives ACIU Alternatives LRMR Alternatives CGC Alternatives FDMT Alternatives YMAB Alternatives OGI Alternatives ENGN Alternatives RAPT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VTVT) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTVT Stock Alerts